Presentation is loading. Please wait.

Presentation is loading. Please wait.

Treatment of bullous pemphigoid with adjuvant immunoadsorption: A case series  Michael Kasperkiewicz, MD, Franziska Schulze, MD, Markus Meier, MD, Nina.

Published byJeffery Scott Modified over 6 years ago

Similar presentations

Presentation on theme: "Treatment of bullous pemphigoid with adjuvant immunoadsorption: A case series  Michael Kasperkiewicz, MD, Franziska Schulze, MD, Markus Meier, MD, Nina."— Presentation transcript:

1 Treatment of bullous pemphigoid with adjuvant immunoadsorption: A case series 
Michael Kasperkiewicz, MD, Franziska Schulze, MD, Markus Meier, MD, Nina van Beek, MD, Martin Nitschke, MD, Detlef Zillikens, MD, Enno Schmidt, MD, PhD  Journal of the American Academy of Dermatology  Volume 71, Issue 5, Pages (November 2014) DOI: /j.jaad Copyright © 2014 American Academy of Dermatology, Inc. Terms and Conditions

2 Fig 1 Patient characteristics and relationship between clinical stages and serum anti-bullous pemphigoid (BP)180 NC16A enzyme-linked immunosorbent assay (ELISA) levels during the course of the disease of 7 patients with BP treated by adjuvant immunoadsorption (IA) in addition to prednisolone (PRE), dapsone (DAP), and topical clobetasol propionate 0.05% ointment (CLO). One patient (4-pointed star) received additional consecutive immunosuppressive treatment with azathioprine/mycophenolate mofetil (MMF) and methotrexate (MTX) because of refractory/new skin lesions, only minor initial reduction of circulating autoantibodies, and concomitant rheumatoid arthritis. In 1 patient (square), who died 3 months after IA, last autoantibody testing was only available 2 months after IA. Another patient (cross) died 10 months after IA. Long interrupted line corresponds to the cut-off of the ELISA (20 U/mL). F, Female; LE, lower extremities; M, male; TR, trunk; UE, upper extremities. Journal of the American Academy of Dermatology  , DOI: ( /j.jaad ) Copyright © 2014 American Academy of Dermatology, Inc. Terms and Conditions

3 Fig 2 Representative clinical pictures of a patient with bullous pemphigoid (multiserrated star in Fig 1) before and 1 month after adjuvant immunoadsorption (IA). Journal of the American Academy of Dermatology  , DOI: ( /j.jaad ) Copyright © 2014 American Academy of Dermatology, Inc. Terms and Conditions

Download ppt "Treatment of bullous pemphigoid with adjuvant immunoadsorption: A case series  Michael Kasperkiewicz, MD, Franziska Schulze, MD, Markus Meier, MD, Nina."

Similar presentations

Molluscum contagiosum infection during the treatment of vitiligo with tacrolimus ointment  Bong Kyun Ahn, MD, Byoung-Dae Kim, MD, Sang Ju Lee, MD, Seung.

Molluscum contagiosum infection during the treatment of vitiligo with tacrolimus ointment  Bong Kyun Ahn, MD, Byoung-Dae Kim, MD, Sang Ju Lee, MD, Seung.
Adalimumab drug survival in patients with psoriasis, Crohn's disease, and rheumatoid arthritis: Relevant differences using the same treatment  Juul M.P.A.

Adalimumab drug survival in patients with psoriasis, Crohn's disease, and rheumatoid arthritis: Relevant differences using the same treatment  Juul M.P.A.
Clavi syphilitici–an unusual presentation of syphilis

Clavi syphilitici–an unusual presentation of syphilis
Optimal time to provide skin cancer and photoprotection education to pediatric solid organ transplant recipients  Lily Chen, BA, Feng Gao, MD, PhD, MPH,

Optimal time to provide skin cancer and photoprotection education to pediatric solid organ transplant recipients  Lily Chen, BA, Feng Gao, MD, PhD, MPH,
Apremilast in the treatment of moderate to severe hidradenitis suppurativa: A case series of 9 patients  Patrizia Weber, MD, S. Morteza Seyed Jafari,

Apremilast in the treatment of moderate to severe hidradenitis suppurativa: A case series of 9 patients  Patrizia Weber, MD, S. Morteza Seyed Jafari,
Facial adenocarcinoma treated with intra-arterial chemotherapy

Facial adenocarcinoma treated with intra-arterial chemotherapy
Striking leflunomide efficacy against refractory cutaneous sarcoidosis

Striking leflunomide efficacy against refractory cutaneous sarcoidosis
Yul W. Yang, MD, PhD, David J. DiCaudo, MD 

Yul W. Yang, MD, PhD, David J. DiCaudo, MD 
Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients  Lucy Y. Liu, BA, Brittany.

Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients  Lucy Y. Liu, BA, Brittany.
Baldness reversed by chemotherapy

Baldness reversed by chemotherapy
Sara B. Ferguson, MD, Elisa S. Gallo, MD  JAAD Case Reports 

Sara B. Ferguson, MD, Elisa S. Gallo, MD  JAAD Case Reports 
Chronic bullous disease of childhood and pneumonia in a neonate with VATERL association and hypoplastic paranasal sinuses  Charissa Mia D. Salud, MD,

Chronic bullous disease of childhood and pneumonia in a neonate with VATERL association and hypoplastic paranasal sinuses  Charissa Mia D. Salud, MD,
Hypertrichosis around a leg ulcer being treated with prostaglandin E1 ointment  Tetsuya Honda, MD, PhD, Satoshi Koreeda, MD, PhD, Yoshiki Miyachi, MD,

Hypertrichosis around a leg ulcer being treated with prostaglandin E1 ointment  Tetsuya Honda, MD, PhD, Satoshi Koreeda, MD, PhD, Yoshiki Miyachi, MD,
Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD 

Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD 
María Jesús Suárez Valladares, MD, Manuel Ángel Rodríguez Prieto, MD 

María Jesús Suárez Valladares, MD, Manuel Ángel Rodríguez Prieto, MD 
Two randomized, double-blind, placebo-controlled studies of fluticasone propionate lotion 0.05% for the treatment of atopic dermatitis in subjects from.

Two randomized, double-blind, placebo-controlled studies of fluticasone propionate lotion 0.05% for the treatment of atopic dermatitis in subjects from.
The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study  Hsien-Yi Chiu, MD, Tsen-Fang.

The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study  Hsien-Yi Chiu, MD, Tsen-Fang.
Adalimumab drug survival in patients with psoriasis, Crohn's disease, and rheumatoid arthritis: Relevant differences using the same treatment  Juul M.P.A.

Adalimumab drug survival in patients with psoriasis, Crohn's disease, and rheumatoid arthritis: Relevant differences using the same treatment  Juul M.P.A.
Re-emergence of anti-topoisomerase I antibody with exacerbated development of skin sclerosis in a patient with systemic sclerosis  Yasuhito Hamaguchi,

Re-emergence of anti-topoisomerase I antibody with exacerbated development of skin sclerosis in a patient with systemic sclerosis  Yasuhito Hamaguchi,
A case of childhood bullous pemphigoid with IgG and IgA autoantibodies to various domains of BP180  Manabu Osawa, MD, Ikuko Ueda-Hayakawa, MD, PhD, Taiki.

A case of childhood bullous pemphigoid with IgG and IgA autoantibodies to various domains of BP180  Manabu Osawa, MD, Ikuko Ueda-Hayakawa, MD, PhD, Taiki.

Similar presentations

Ads by Google